Table 3.
Study Drug-Related Treatment-Emergent Adverse Events in Combined Parts 1 and 2
AEs, n (%) | Total golodirsen group (n = 25) |
---|---|
Any TEAE related to study drug | 9 (36.0) |
Pyrexia | 3 (12.0) |
Headache | 2 (8.0) |
Proteinuria | 2 (8.0) |
Syncope | 1 (4.0) |
Erythema | 1 (4.0) |
Rash | 1 (4.0) |
Skin exfoliation | 1 (4.0) |
Sinus tachycardia | 1 (4.0) |
Tachycardia | 1 (4.0) |
Gastroenteritis | 1 (4.0) |
Blood pressure decreased | 1 (4.0) |
Hyperglycemia | 1 (4.0) |
TEAE, treatment-emergent adverse event.